Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases

International Journal of Cancer

Volumn 129, Issue 8, 2011, Pages 1923-1931

  Tian, Liyuan ^a   Wang, Yu ^a   Xu, Dabin ^a   Gui, Junhao ^a   Jia, Xingwang ^a   Tong, Hongli ^a   Wen, Xinyu ^a   Dong, Zhennan ^a   Tian, Yaping ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

alpha fetoprotein; cirrhosis; golgi protein 73; hepatocellular carcinoma; serum

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GOLGI PROTEIN 73; MEMBRANE PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; ADVANCED CANCER; ARTICLE; BILE DUCT CARCINOMA; CHRONIC DISEASE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DISPLAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FIBROSIS; LIVER HEMANGIOMA; LIVER HYPERPLASIA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; QUANTITATIVE DIAGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 80051726168     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25838     Document Type: Article

References (34)

1. Altekruse SF, McGlynn KA, Reichman ME,. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009; 27: 1485-91.
2. Yuen MF, Hou JL, Chutaputti A,. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol 2009; 24: 346-53.
3. JO O,. Hepatocellular carcinoma in the developing world. Semin Oncol 2001; 28: 9.
4. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF Jr,. International trends and patterns of primary liver cancer. Int J Cancer 2001; 94: 290-6. (Pubitemid 32911426)
5. Vanhooren V, Liu XE, Franceschi C, Gao CF, Libert C, Contreras R, Chen C,. N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing. Mech Ageing Dev 2009; 130: 92-7.
6. Kudo T, Nakagawa H, Takahashi M, Hamaguchi J, Kamiyama N, Yokoo H, Nakanishi K, Nakagawa T, Kamiyama T, Deguchi K, Nishimura S, Todo S,. N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma. Mol Cancer 2007; 6: 32.
7. Kladney RD, Bulla GA, Guo L, Mason AL, Tollefson AE, Simon DJ, Koutoubi Z, Fimmel CJ,. GP73, a novel Golgi-localized protein upregulated by viral infection. Gene 2000; 249: 53-65. (Pubitemid 30300752)
8. Iftikhar R, Kladney RD, Havlioglu N, Schmitt-Graff A, Gusmirovic I, Solomon H, Luxon BA, Bacon BR, Fimmel CJ,. Disease- and cell-specific expression of GP73 in human liver disease. Am J Gastroenterol 2004; 99: 1087-95. (Pubitemid 38917813)
9. Riener MO, Stenner F, Liewen H, Soll C, Breitenstein S, Pestalozzi BC, Samaras P, Probst-Hensch N, Hellerbrand C, Mullhaupt B, Clavien PA, Bahra M, et al. Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology 2009; 49: 1602-9.
10. Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ,. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology 2002; 35: 1431-40. (Pubitemid 34966897)
11. Maitra A, Thuluvath PJ,. GP73 and liver disease: a (Golgi) complex enigma. Am J Gastroenterol 2004; 99: 1096-8. (Pubitemid 38917814)
12. Hu JS, Wu DW, Liang S, Miao XY,. GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population. Med Oncol 2010; 27: 339-45.
13. Block TM, Comunale MA, Lowman M, Steel LF, Romano PR, Fimmel C, Tennant BC, London WT, Evans AA, Blumberg BS, Dwek RA, Mattu TS, et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci USA 2005; 102: 779-84. (Pubitemid 40282742)
14. Drake RR, Schwegler EE, Malik G, Diaz J, Block T, Mehta A, Semmes OJ,. Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol Cell Proteomics 2006; 5: 1957-67. (Pubitemid 44688203)
15. Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D'Amelio A, Lok AS, Block TM,. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol 2005; 43: 1007-12. (Pubitemid 41627986)
16. Gu Y, Chen W, Zhao Y, Chen L, Peng T,. Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases. Ann Clin Biochem 2009; 46: 38-43.
17. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS,. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 2005; 42: 218-24. (Pubitemid 40143468)
18. 2004 guidelines for surgical treatment of primary hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi 2005; 13: 329-30.
19. The guidelines of prevention and treatment for chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2005; 13: 881-91.
20. Guideline of prevention and treatment of hepatitis C. Zhonghua Yu Fang Yi Xue Za Zhi 2004; 38: 210-5.
21. Befeler AS, Di Bisceglie AM,. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002; 122: 1609-19. (Pubitemid 34533556)
22. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R,. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
23. Child CG, Turcotte JG,. Surgery and portal hypertension. Major Probl Clin Surg 1964; 1: 1-85.
24. Mao YL, Yang HY, Xu HF, Sang XT, Lu X, Yang ZY, Zhang JC, Zhong SX, Huang JF, Zhang HB,. Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study. Zhonghua Yi Xue Za Zhi 2008; 88: 948-51. (Pubitemid 351844034)
25. Luo RH, Zhao ZX, Zhou XY, Gao ZL, Yao JL,. Risk factors for primary liver carcinoma in Chinese population. World J Gastroenterol 2005; 11: 4431-4.
26. Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000; 15: 1356-61. (Pubitemid 32052906)
27. Makuuchi M, Kokudo N, Arii S, Futagawa S, Kaneko S, Kawasaki S, Matsuyama Y, Okazaki M, Okita K, Omata M, Saida Y, Takayama T, et al. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 2008; 38: 37-51. (Pubitemid 350182575)
28. El-Serag HB, Marrero JA, Rudolph L, Reddy KR,. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 134: 1752-63. (Pubitemid 351615415)
29. Carpino G, Franchitto A, Morini S, Corradini SG, Merli M, Gaudio E,. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study. Ital J Anat Embryol 2004; 109: 225-38. (Pubitemid 40179331)
30. Mao YL, Yang HY, Xu HF, Sang XT, Lu X, Yang ZY, Zhang JC, Zhong SX, Huang JF, Zhang HB,. Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study. Zhonghua Yi Xue Za Zhi 2008; 88: 948-51. (Pubitemid 351844034)
31. Hoshino H, Konda Y, Takeuchi T,. Co-expression of the proprotein-processing endoprotease furin and its substrate transforming growth factor beta1 and the differentiation of rat hepatocytes. FEBS Lett 1997; 419: 9-12. (Pubitemid 28011206)
32. Bachert C, Fimmel C, Linstedt AD,. Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma. Traffic 2007; 8: 1415-23. (Pubitemid 47394245)
33. Schrohl AS, Holten-Andersen M, Sweep F, Schmitt M, Harbeck N, Foekens J, Brunner N,. Tumor markers: from laboratory to clinical utility. Mol Cell Proteomics 2003; 2: 378-87.
34. Kristiansen G, Fritzsche FR, Wassermann K, Jager C, Tolls A, Lein M, Stephan C, Jung K, Pilarsky C, Dietel M, Moch H,. GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer 2008; 99: 939-48.